Carfilzomib Alternatives Compared
Carfilzomib | Revlimid (lenalidomide) | Darzalex (daratumumab) |
|
---|
Carfilzomib | Revlimid (lenalidomide) | Darzalex (daratumumab) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multiple Myeloma. Carfilzomib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Follicular Lymphoma, Anemia, Mantle Cell Lymphoma, Lymphoma, Marginal Zone Lymphoma, Multiple Myeloma, Myelodysplastic Diseases. Revlimid may also be used for purposes not listed in... View more |
Prescription only
Darzalex is a CD38 monoclonal antibody that may be used to treat Multiple Myeloma, usually in combination with other treatments. It is given by infusion and upper respiratory tract infections... View more |
Related suggestions Multiple Myeloma
|
|||||||||||||||
More about Carfilzomib | More about Revlimid (lenalidomide) | More about Darzalex (daratumumab) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Carfilzomib has an average rating of 6.6 out of 10 from a total of 5 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 20% reported a negative effect. |
Revlimid has an average rating of 7.0 out of 10 from a total of 27 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 17% reported a negative effect. |
Darzalex has an average rating of 7.8 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
N/A |
|||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Revlimid prices |
View all Darzalex prices |
||||||||||||||||
Dosage Forms Available | ||||||||||||||||||
N/A |
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
Kyprolis |
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
1 hour |
3 hours |
432 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 342 drugs are known to interact with Carfilzomib:
|
A total of 270 drugs are known to interact with Revlimid:
|
A total of 173 drugs are known to interact with Darzalex:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
N/A |
December 27, 2005 |
November 16, 2015 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.